Alexion Pharmaceuticals Inc (ALXN)

182.50 +0.00  +0.00% NASDAQ Jul 21, 20:00 USD
View Full Chart
Price Chart
View All ALXN News


View All Events


Date Type Description
07/30/2021 08:00 EST Earnings Calls Q2 2021 Earnings Call
07/30/2021 Earnings Results Q2 2021 Earnings Results
04/30/2021 Earnings Results Q1 2021 Earnings Results
02/04/2021 Earnings Results Q4 2020 Earnings Results
10/29/2020 Earnings Results Q3 2020 Earnings Results
10/29/2020 08:00 EST Earnings Calls Q3 2020 Earnings Call
07/30/2020 08:00 EST Earnings Calls Q2 2020 Earnings Call
07/30/2020 Earnings Results Q2 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • Description: Alexion Pharmaceuticals specializes in developing and marketing drugs for rare, life-threatening medical conditions. Its blockbuster product, Soliris, is approved for paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD). Next-generation Ultomiris is approved in PNH and aHUS. Strensiq and Kanuma target ultrarare metabolic diseases. Alexion's pipeline targets rare diseases with high unmet need in hematology, nephrology, metabolic diseases, neurology, cardiology, and other areas.
  • URL:
  • Investor Relations URL:
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Large Cap/Blend
  • Next Earnings Release: Jul. 30, 2021
  • Last Earnings Release: Apr. 30, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
BCLPX BlackRock Event Driven Equity Inv C 5.83%
MERFX Merger Investor 4.96%
BBH VanEck Vectors Biotech ETF 4.94%
ARBCX Arbitrage C 3.69%
FMQSX Franklin Mutual Quest R 2.93%
BIB ProShares Ultra Nasdaq Biotechnology 2.70%
FBCV Fidelity® Blue Chip Value ETF 1.83%
HQL Tekla Life Sciences Investors 1.82%
FNKLX Fidelity® Series Value Discovery 1.70%
COWZ Pacer US Cash Cows 100 ETF 1.67%
ZUH.TO BMO Eq Wght US HlthCare Hdgd to CAD ETF 1.47%
TDB927 TD Global Growth Fund O Ser 1.23%





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.